Speakers
Dr Devin Gray General Practitioner, Putneymead Group Medical Practice, Putney, London
Dr Tina Chrysochou Consultant Nephrologist, Salford Royal Hospital; Honorary Senior Lecturer, University of Manchester
Learning objectives
-
- To gain insights into how to identify patients with renal disease and what testing should be offered
- To provide an overview of management strategies available to reduce the risk of renal disease progression and cardiovascular disease
- To discuss the importance of patient education in the management of renal disease
References
1. Moffatt RJ, Stamford B (eds). Lipid Metabolism and Health, 1st edition. Boca Raton: CRC Press, 2005. https://www.taylorfrancis.com/books/mono/10.1201/9781420038422/lipid-metabolism-health-robert-moffatt-bryant-stamford
2. Blaha MJ et al. J Clin Lipidol 2008;2:267–2739. https://www.lipidjournal.com/article/S1933-2874(08)00274-2/fulltext
3. NHS England. Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD. 2022. Available from: https://www.england.nhs.uk/aac/wp-content/uploads/sites/50/2020/04/lipid-management-pathway-v6.pdf (accessed January 2024).
4. Stroes ES et al. Eur Heart J 2015;36:1012–1022. https://academic.oup.com/eurheartj/article/36/17/1012/2465952
5. Feingold KR (eds). Cholesterol Lowering Drugs, 1st edition. South Dartmouth: MDText.com, 2016. https://www.ncbi.nlm.nih.gov/books/NBK395573/